tirzepatide type 1 diabetes trial for diabetes: on track to SURPASS current therapy Tirzepatide's Prediabetes Triumph - Cardiac

Northwestern Medicine Staff

We also learned these gastrointestinal symptoms were most intense during the dose escalation phases, and tended to diminish significantly with continued treatment at a stable dose

Side effects were consistent with the GLP-1 class, primarily mild to moderate nausea and diarrhea

10.1038/nrc2228 Nat

Semaglutide and Alcohol Use Disorder Rong Xu and Nora Volkow also recently published this new study of patient health records in Nature Communications that shows a 50-56% decrease in the risk of new or recurring alcohol addictions among people taking semaglutide

Whilst this once-weekly injectable medication effectively lowers blood sugar and promotes weight loss, patients may wonder about potential side effects, including whether Ozempic causes hearing loss